时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
This study aimed to investigate the association between rectus femoris thickness (RFT) and rectus femoris cross-sectional area (RFCSA) measured by USG and hospitalization in patients with cirrhosis.
方法
This study aimed to investigate the association between rectus femoris thickness (RFT) and rectus femoris cross-sectional area (RFCSA) measured by USG and hospitalization in patients with cirrhosis.；This retrospective, single-center study included 58 patients with cirrhosis followed at Hacettepe University Faculty of Medicine Hospital between August 2021 and April 2023.
核心结论
Sarcopenia is a common complication of liver cirrhosis and is associated with adverse clinical outcomes, including increased hospitalization.；Multivariable logistic regression analyses were performed to identify independent factors associated with hospitalization.；Patients with hospitalization had significantly lower body mass index and significantly higher Model for End-Stage Liver Disease sodium (MELD-Na) and Model for End-Stage Liver Disease 3.0 scores compared with those without hospitalization.；RFT and RFCSA measured by USG were significantly lower in hospitalized patients (P = 0.011 and P = 0.032, respectively).；In multivariable logistic regression analyses, RFT remained associated with hospitalization after adjustment for age, sex, and MELD-Na (OR, 0.78; 95% CI, 0.63-0.96; P = 0.021).；Similarly, RFCSA was associated with hospitalization (OR, 0.73; 95% CI, 0.54-0.99: P = 0.043).
局限
This study aimed to investigate the association between rectus femoris thickness (RFT) and rectus femoris cross-sectional area (RFCSA) measured by USG and hospitalization in patients with cirrhosis.
对本项目的价值
观察性关联，仅用于假说生成，不可作因果：功能结局（衰弱 / 肌少症）是临床转化最可及的终点，适合作为一期终点候选。 ｜ 价值分 1.0/5（★☆☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：Rectus femoris ultrasound as a rapid bedside tool associated with 1-year hospitalization in cirrhosis: A retrospective study.
- 期刊与标识：Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · PMID 42951881 · DOI 10.1002/ncp.70201
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。